Inhibition of tumor growth by DT-A expressed under the control of IGF2 P3 and P4 promoter sequences

Molecular Therapy

Volumn 7, Issue 4, 2003, Pages 535-541

  Ayesh, Basim ^a   Matouk, I ^a   Ohana, P ^a   Sughayer, M A ^b   Birman, T ^c   Ayesh, S ^a   Schneider, T ^a   de Groot, N ^a   Hochberg, A ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b AL QUDS UNIVERSITY   (Palestine)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Bladder cancer; Diphtheria toxin; Gene therapy; IGF2; Insulin like growth factor 2; Regulatory sequences

Indexed keywords

DIPHTHERIA TOXIN; LUCIFERASE; MESSENGER RNA; SOMATOMEDIN B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CANCER THERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DESIGN; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH;

ANIMALIA; VECTORS;

EID: 0038027292     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-0016(03)00056-X     Document Type: Article

References (34)

1. Pow-Sang, J. M., and Seigne, J. D. (2000). Contemporary management of superficial bladder cancer. Cancer Control 7(4): 335-339.
2. Abdul-Ghani, R., Ohana, P., Matouk, I., Ayesh, S., Ayesh, B., Laster, M., Bibi, O., Giladi, H., Molnar-Kimber, K., Sughayer, M. A., de Groot, N., and Hochberg, A. (2000). Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cells. Mol. Ther. 2: 539-544.
3. Ohana, P., Bibi, O., Matouk, I., Levy, C., Birman, T., Ariel, I., Schneider, T., Ayesh, S., Giladi, H., Laster, M., de Groot, N., and Hochberg, A. (2002). Use of H19 regulatory sequences for targeted gene therapy in cancer. Int. J. Cancer 98: 645-650.
4. Lidor, Y. J., Lee, W. E., Nilson, J. H., Maxwell, I. H., Su, L. J., Brand, E., and Glode, L. M. (1997). In vitro expression of the diphtheria toxin A-chain gene under the control of human chorionic gonadotropin gene promoters as a means of directing toxicity to ovarian cancer cell lines. Am. J. Obstet. Gynecol. 177: 579-585.
5. Maxwell, I. H., Glode, L. M., and Maxwell, F. (1992). Expression of diphtheria toxin A-chain in mature B-cells: a potential approach to therapy of B-lymphoid malignancy. Leuk. Lymphoma 7: 457-462.
6. Massuda, E. S., Dunphy, E. J., Redman, R. A., Schreiber, J. J., Nauta, L. E., Barr, F. G., Maxwell, I. H., and Cripe, T. P. (1997). Regulated expression of the diphtheria toxin A chain by a tumor-specific chimeric transcription factor results in selective toxicity for alveolar rhabdomyosarcoma cells. Proc. Natl. Acad. Sci. USA 94: 14701-14706.
7. Maxwell, F., Maxwell, I. H., and Glode, L. M. (1987). Cloning, sequence determination, and expression in transfected cells of the coding sequence for the tox 176 attenuated diphtheria toxin A chain. Mol. Cell Biol. 7: 1576-1579.
8. Choo, Y., Sanchez-Garcia, I., and Klug, A. (1994). In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence. Nature 372: 642-645.
9. Sandvig, K., and van Deurs, B. (1992). Toxin-induced cell lysis: protection by 3-methy-ladenine and cycloheximide. Exp. Cell Res. 200: 253-262.
10. Engstrom, W., Shokrai, A., Otte, K., Granerus, M., Gessbo, A., Bierke, P., Madej, A., Sjolund, M., and Ward, A. (1998). Transcriptional regulation and biological significance of the insulin like growth factor II gene. Cell Prolif. 31: 173-189.
11. Holthuizen, P. E., Cleutjens, C. B., Veenstra, G. J., van der Lee, F. M., Koonen-Reemst, A. M., and Sussenbach, J. S. (1993). Differential expression of the human, mouse and rat IGF-II genes. Regul. Pept. 48: 77-89.
12. Pagter-Holthuizen, P., Jansen, M., van Schaik, F. M., van der, K. R., Oosterwijk, C., Van den Brande, J. L., and Sussenbach, J. S. (1987). The human insulin-like growth factor II gene contains two development-specific promoters. FEBS Lett. 214: 259-264.
13. Pagter-Holthuizen, P., Jansen, M., van der Kammen, R. A., van Schaik, F. M., and Sussenbach, J. S. (1988). Differential expression of the human insulin-like growth factor II gene. Characterization of the IGF-II mRNAs and an mRNA encoding a putative IGF-II-associated protein. Biochim. Biophys. Acta 950: 282-295.
14. Holthuizen, P., van der Lee, F. M., Ikejiri, K., Yamamoto, M., and Sussenbach, J. S. (1990). Identification and initial characterization of a fourth leader exon and promoter of the human IGF-II gene. Biochim. Biophys. Acta 1087: 341-343.
15. Giannoukakis, N., Deal, C., Paquette, J., Goodyer, C. G., and Polychronakos, C. (1993). Parental genomic imprinting of the human IGF2 gene. Nat. Genet. 4: 98-101.
16. Ekstrom, T. J., Cui, H., Li, X., and Ohlsson, R. (1995). Promoter-specific IGF2 imprinting status and its plasticity during human liver development. Development 121: 309-316.
17. Ohlsson, R., and Franklin, G. (1995). Normal development and neoplasia: the imprinting connection. Int. J. Dev. Biol. 39: 869-876.
18. Morison, I. M., and Reeve, A. E. (1998). Insulin-like growth factor 2 and overgrowth: molecular biology and clinical implications. Mol. Med. Today 4: 110-115.
19. Wu, H. K., Squire, J. A., Catzavelos, C. G., and Weksberg, R. (1997). Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas. Biochem. Biophys. Res. Commun. 235: 123-129.
20. Ross, J. A., Schmidt, P. T., Perentesis, J. P., and Davies, S. M. (1999). Genomic imprinting of H19 and insulin-like growth factor-2 in pediatric germ cell tumors. Cancer 85: 1389-1394.
21. Hahn, H., Wojnowski, L., Specht, K., Kappler, R., Calzada-Wack, J., Potter, D., Zimmer, A., Muller, U., Samson, E., Quintanilla-Martinez, L., and Zimmer, A. (2000). Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma. J. Biol. Chem. 275: 28341-28344.
22. Lee, Y. I., Lee, S., Das, G. C., Park, U. S., Park, S. M., and Lee, Y. I. (2000). Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma. Oncogene 19: 3717-3726.
23. Bae, S. K., Bae, M. H., Ahn, M. Y., Son, M. J., Lee, Y. M., Bae, M. K., Lee, O. H., Park, B. C., and Kim, K. W. (1999). Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia. Cancer Res. 59: 5989-5994.
24. Mineo, R., Fichera, E., Liang, S. J., and Fujita-Yamaguchi, Y. (2000). Promoter usage for insulin-like growth factor-II in cancerous and benign human breast, prostate, and bladder tissues, and confirmation of a 10th exon. Biochem. Biophys. Res. Commun. 268(3): 886-892.
25. Sohda, T., Yun, K., Iwata, K., Soejima, H., and Okumura, M. (1996). Increased expression of insulin-like growth factor 2 in hepatocellular carcinoma is primarily regulated at the transcriptional level. Lab Invest 75: 307-311.
26. Li, S. L., Goko, H., Xu, Z. D., Kimura, G., Sun, Y., Kawachi, M. H., Wilson, T. G., Wilczynski, S., and Fujita-Yamaguchi, Y. (1998). Expression of insulin-like growth factor (IGF)-II in human prostate, breast, bladder, and paraganglioma tumors. Cell Tissue Res. 291: 469-479.
27. Fichera, E., Liang, S., Xu, Z., Guo, N., Mineo, R., and Fujita-Yamaguchi, Y. (2000). A quantitative reverse transcription and polymerase chain reaction assay for human IGF-II allows direct comparison of IGF-II mRNA levels in cancerous breast, bladder, and prostate tissues. Growth Horm. IGF. Res. 10(2): 61-70.
28. Rasmussen, A. A., and Cullen, K. J. (1998). Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors. Breast Cancer Res. Treat. 47: 219-233.
29. Kawamoto, K., Onodera, H., Kan, S., Kondo, S., and Imamura, M. (1999). Possible paracrine mechanism of insulin-like growth factor-2 in the development of liver metastases from colorectal carcinoma. Cancer 85: 18-25.
30. Kawamoto, K., Onodera, H., Kondo, S., Kan, S., Ikeuchi, D., Maetani, S., and Imamura, M. (1998). Expression of insulin-like growth factor-2 can predict the prognosis of human colorectal cancer patients: correlation with tumor progression, proliferative activity and survival. Oncology 55: 242-248.
31. Kopf, E., Bibi, O., Ayesh, S., Tykocinski, M., Vitner, K., Looijenga, L. H., de Groot, N., and Hochberg, A. (1998). The effect of retinoic acid on the activation of the human H19 promoter by a 3′ downstream region. FEBS Lett. 432: 123-127.
32. Futscher, B. W., Blake, L. L., Gerlach, J. H., Grogan, T. M., and Dalton, W. S. (1993). Quantitative polymerase chain reaction analysis of mdr1 mRNA in multiple myeloma cell lines and clinical specimens. Anal. Biochem. 213: 414-421.
33. Ariel, I., Miao, H. Q., Ji, X. R., Schneider, T., Roll, D., de Groot, N., Hochberg, A., and Ayesh, S. (1998). Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma. Mol. Pathol. 51: 21-25.
34. Gorman, C. M., Moffat, L. F., and Howard, B. H. (1982). Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell Biol. 2: 1044-1051.